MicroPort NeuroTech is a part of Microport Scientific Corporation, actively involved in pioneering neuro-interventional medical devices since 2002. The company is primarily dedicated to offering universal stroke treatment solutions, evident from their comprehensive product portfolio that spans across three major neurovascular disease areas. With 12 approved products utilized in over 1998 hospitals globally, MicroPort NeuroTech supports an average of 134 surgeries each day and has obtained 109 authorized patents domestically and internationally. The company, headquartered in Shanghai Zhangjiang Science City, has a workforce of over 400 employees, constantly striving to innovate solutions for neurovascular stroke disorders. The recent $150.00M Venture Round investment on 12 November 2021 involved CICC Healthcare Investment Fund and Huayi Capital. For more details, visit MicroPort NeuroTech's website.
No recent news or press coverage available for MicroPort NeuroTech.